Ratiometric delivery of cisplatin and doxorubicin using tumour-targeting carbon-nanotubes entrapping platinum(iv) prodrugs

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

(2012) Che-Ming Jack Hu et al.   BIOCHEMICAL PHARMACOLOGY

Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design

(2012) Jenny Z. Zhang et al.   CHEMISTRY-A EUROPEAN JOURNAL

Drug Resistance: Challenges to Effective Therapy

(2012) M. P.V. Shekhar   CURRENT CANCER DRUG TARGETS

Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum(iv) prodrugs

(2012) Daniel Yuan Qiang Wong et al.   DALTON TRANSACTIONS

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck

(2012) Felix Keil et al.   EUROPEAN JOURNAL OF CANCER

Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation

(2012) Chee Fei Chin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Platinum(iv) prodrugs entrapped within multiwalled carbon nanotubes: Selective release by chemical reduction and hydrophobicity reversal

(2012) Jian Li et al.   Chemical Science

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes

(2011) Elena Heister et al.   CARBON

Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity

(2011) Nora Graf et al.   CHEMBIOCHEM

Studies of Glutathione Transferase P1-1 Bound to a Platinum(IV)-Based Anticancer Compound Reveal the Molecular Basis of Its Activation

(2011) Lorien J. Parker et al.   CHEMISTRY-A EUROPEAN JOURNAL

Mono-carboxylated diaminedichloridoplatinum(iv) complexes – selective synthesis, characterization, and cytotoxicity

(2011) Verena Pichler et al.   DALTON TRANSACTIONS

Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system

(2011) Zongfei Ji et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Crucial Parameters Responsible for Carbon Nanotubes Toxicity

(2010) Tapas Nayak et al.   Current Nanoscience

Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma

(2010) M. Honda et al.   DISEASES OF THE ESOPHAGUS

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

(2010) Giuseppe Colucci et al.   JOURNAL OF CLINICAL ONCOLOGY

Polymer-Caged Nanobins for Synergistic Cisplatin−Doxorubicin Combination Chemotherapy

(2010) Sang-Min Lee et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Transcription Inhibition by Platinum−DNA Cross-Links in Live Mammalian Cells

(2010) Wee Han Ang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

(2010) N. Kolishetti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers

(2009) Twan Lammers et al.   BIOMATERIALS

Inhibition of transcription by platinum antitumor compounds

(2009) Ryan C. Todd et al.   Metallomics

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY

Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature

(2007) Sumitra Mukhopadhyay et al.   BIOCONJUGATE CHEMISTRY